Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
917.90
3.05
(0.33%)
< Home
< Back
Natco Pharma Ltd. News
>>
Natco Pharma - Quaterly Results
>>
Natco Pharma - Quaterly Results
>>
Natco Pharma submits analyst meet intimation
>>
Natco Pharma receives approval for ANDA for Bosentan tablets
>>
NATCO Pharma informs about press release
>>
Natco Pharma gets ANDA approval for Everolimus tablets for oral suspension
>>
NATCO Pharma informs about sustainability report
>>
Natco Pharma informs about details of loss of certificate
>>
Natco Pharma - Quaterly Results
>>
Natco Pharma - Quaterly Results
<<
<
3
4
5
...52
>
>>